About this episode

Jacob Kimmel discusses how NewLimit utilizes AI to develop therapies aimed at extending healthspans by reprogramming cells.

Leveraging a career focused on the biology of aging, Jacob Kimmel explains how NewLimit uses advanced AI to navigate vast genetic combinations and prioritize experiments that reprogram cells to more youthful, functional states. With a large-scale data library, a small team, and a novel approach, NewLimit is developing therapies to enable longer, healthier lives.

People in this episode

Guest: Jacob Kimmel

Topics covered

• AI
• healthspan
• biology of aging
• genetic combinations
• therapies
• cell reprogramming

Keywords

• AI
• healthspan
• NewLimit
• cell reprogramming
• aging
• therapies
• genetics

Mentioned in this episode

Organizations: NewLimit

Explore listener stats, chart rankings, contacts and more on the The Future of Healthcare AI podcast page.